Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  54,357 results for ""CD40 Ligand""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Oncolytic adenovirus encoding decorin and CD40 ligand inhibits tumor growth and liver metastasis via immune activation in murine colorectal tumor model.

  • Authors : Rong Y; Department of Experimental Medical Science, Ningbo No.2 Hospital, Ningbo, 315010, China.; Ning Y

Subjects: Colorectal Neoplasms*/Colorectal Neoplasms*/Colorectal Neoplasms*/therapy ; Colorectal Neoplasms*/Colorectal Neoplasms*/Colorectal Neoplasms*/pathology ; Colorectal Neoplasms*/Colorectal Neoplasms*/Colorectal Neoplasms*/immunology

  • Source: Molecular biomedicine [Mol Biomed] 2024 Sep 22; Vol. 5 (1), pp. 39. Date of Electronic Publication: 2024 Sep 22.Publisher: Springer Singapore Country of Publication: Singapore NLM ID: 9918283581406676 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Soluble CD40 Ligand as a Promising Biomarker in Cancer Diagnosis.

  • Authors : Pazoki A; Department of Immunology, School of Medicine, Semnan University of Medical Sciences, Semnan 35147-99442, Iran.; Dadfar S

Subjects: CD40 Ligand*/CD40 Ligand*/CD40 Ligand*/metabolism ; Neoplasms*/Neoplasms*/Neoplasms*/diagnosis ; Neoplasms*/Neoplasms*/Neoplasms*/metabolism

  • Source: Cells [Cells] 2024 Jul 28; Vol. 13 (15). Date of Electronic Publication: 2024 Jul 28.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101600052 Publication Model: Electronic Cited Medium: Internet ISSN: 2073-4409

Record details

Read More Add to Saved list
×
Academic Journal

Investigating soluble CD40 ligand as a prognostic factor among acute coronary syndromes patients: A multi-center prospective case-control study.

  • Authors : Nofal R; Faculty of Medicine, Damascus University, Damascus, Syria.; Martini N

Subjects: Acute Coronary Syndrome*/Acute Coronary Syndrome*/Acute Coronary Syndrome*/blood ; Acute Coronary Syndrome*/Acute Coronary Syndrome*/Acute Coronary Syndrome*/diagnosis ; CD40 Ligand*/CD40 Ligand*/CD40 Ligand*/blood

  • Source: Medicine [Medicine (Baltimore)] 2024 Sep 27; Vol. 103 (39), pp. e39891.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 2985248R Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

CD40 ligand antagonist dazodalibep in Sjögren's disease: a randomized, double-blinded, placebo-controlled, phase 2 trial.

  • Authors : St Clair EW; Division of Rheumatology and Immunology, Duke University Department of Medicine, Durham, NC, USA. .; Baer AN

Subjects: Sjogren's Syndrome*/Sjogren's Syndrome*/Sjogren's Syndrome*/immunology ; Sjogren's Syndrome*/Sjogren's Syndrome*/Sjogren's Syndrome*/drug therapy ; CD40 Ligand*/CD40 Ligand*/CD40 Ligand*/antagonists & inhibitors

  • Source: Nature medicine [Nat Med] 2024 Jun; Vol. 30 (6), pp. 1583-1592. Date of Electronic Publication: 2024 Jun 05.Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

CD40 stimulation via CD40 ligand enhances adenovirus-mediated tumour immunogenicity including 'find-me', 'eat-me', and 'kill-me' signalling.

  • Authors : Naseri S; Department of Immunology, Genetics and Pathology (IGP), Science for Life Laboratories, Uppsala University, Uppsala, Sweden.; Cordova MM

Subjects: CD40 Ligand*/CD40 Ligand*/CD40 Ligand*/genetics ; Neoplasms*; Humans

  • Source: Journal of cellular and molecular medicine [J Cell Mol Med] 2024 Apr; Vol. 28 (7), pp. e18162.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101083777 Publication Model: Print Cited Medium: Internet ISSN: 1582-4934

Record details

Read More Add to Saved list
×
Academic Journal

Pneumocystis murina lesions in lungs of experimentally infected Cd40l -/- mice.

  • Authors : Cappelleri A; Department of Veterinary Medicine and Animal Sciences, University of Milan, Lodi, Italy.; Mouse and Animal Pathology Laboratory (MAPLab), UniMi Foundation, Milan, Italy.

Subjects: Pneumocystis* ; Lung*/Lung*/Lung*/pathology ; Lung*/Lung*/Lung*/microbiology

  • Source: Veterinary pathology [Vet Pathol] 2024 Nov; Vol. 61 (6), pp. 988-997. Date of Electronic Publication: 2024 May 17.Publisher: Sage Country of Publication: United States NLM ID: 0312020 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1544-2217

Record details

Read More Add to Saved list
×
Academic Journal

Impact of CD40 (rs1883832) and CD40L (rs1126535) gene variants on laryngeal cancer susceptibility and their association with serum biomarker levels of sCD40 and sCD40L.

  • Authors : Gümüş A; Medical Biochemistry Laboratory, Çam Sakura City Hospital, University of Health Sciences, Istanbul, Turkey.; Institute of Health Sciences, Istanbul University, Istanbul, Turkey.

Subjects: Laryngeal Neoplasms*/Laryngeal Neoplasms*/Laryngeal Neoplasms*/genetics ; Laryngeal Neoplasms*/Laryngeal Neoplasms*/Laryngeal Neoplasms*/blood ; CD40 Antigens*/CD40 Antigens*/CD40 Antigens*/genetics

  • Source: PloS one [PLoS One] 2024 Dec 03; Vol. 19 (12), pp. e0312576. Date of Electronic Publication: 2024 Dec 03 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Mechanotransduction governs CD40 function and underlies X-linked hyper-IgM syndrome.

  • Authors : Choi HK; Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA 30332, USA.; Parker H. Petit Institute for Bioengineering and Biosciences, Georgia Institute of Technology, Atlanta, GA 30332, USA.

Subjects: CD40 Antigens*/CD40 Antigens*/CD40 Antigens*/metabolism ; CD40 Antigens*/CD40 Antigens*/CD40 Antigens*/genetics ; Mechanotransduction, Cellular*

  • Source: Science advances [Sci Adv] 2024 Nov 15; Vol. 10 (46), pp. eadl5815. Date of Electronic Publication: 2024 Nov 15.Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101653440 Publication Model: Print-Electronic

Record details

Read More Add to Saved list
×
Academic Journal

Small-molecule inhibitors of the CD40-CD40L costimulatory interaction are effective in pancreatic islet transplantation and prevention of type 1 diabetes models.

  • Authors : Chuang ST; Diabetes Research Institute, Miller School of Medicine, University of Miami, Miami, FL, United States.; Alcazar O

Subjects: Islets of Langerhans Transplantation*/Islets of Langerhans Transplantation*/Islets of Langerhans Transplantation*/methods ; Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/immunology ; Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/prevention & control

  • Source: Frontiers in immunology [Front Immunol] 2024 Nov 13; Vol. 15, pp. 1484425. Date of Electronic Publication: 2024 Nov 13 (Print Publication: 2024).Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Oncolytic adenovirus MEM-288 encoding membrane-stable CD40L and IFNβ induces an anti-tumor immune response in high grade serous ovarian cancer.

  • Authors : Peters PN; Duke University Department of Obstetrics and Gynecology. Electronic address: .; Whitaker RS

Subjects: Ovarian Neoplasms*/Ovarian Neoplasms*/Ovarian Neoplasms*/therapy ; Ovarian Neoplasms*/Ovarian Neoplasms*/Ovarian Neoplasms*/immunology ; Ovarian Neoplasms*/Ovarian Neoplasms*/Ovarian Neoplasms*/pathology

  • Source: Neoplasia (New York, N.Y.) [Neoplasia] 2024 Nov; Vol. 57, pp. 101056. Date of Electronic Publication: 2024 Sep 13.Publisher: Elsevier Country of Publication: United States NLM ID: 100886622 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
  • 1-10 of  54,357 results for ""CD40 Ligand""